Crescent Capital is a Belfast based venture capital fund manager. Their Primary Investment focus is with Northern Ireland based companies operating in the information technology, life sciences and manufacturing sectors.
| Company | Date | Round | Size | Participants |
| Taykey | 6/11 | Series B | $9M | 3 |
| XConnect Global Networks | 9/09 | Series B | $10M | 4 |
| Axis Three | 6/09 | Venture Round | $3.27M | 3 |
| Fusion Antibodies | 7/07 | Venture Round | $2.5M | 5 |
| Lagan Technologies | 6/06 | Venture Round | $11.2M | 5 |
